Abbott Laboratories Inc en UPDATE 4-Abbott results bode well for spun-off AbbVie <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Abbott 2013 profit forecast slightly above Street view</p> <p>* Humira sales growth a good sign for AbbVie</p> <p>* Abbott shares slip; AbbVie shares rise 3.8 percent</p> <p>By Ransdell Pierson</p> <p>Jan 23 (Reuters) - AbbVie Inc, the new branded pharmaceuticals company spun off by Abbott Laboratories Inc , is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products in its medicine chest.</p> <p><a href="" target="_blank">read more</a></p> Abbott Laboratories Abbott Laboratories Inc AbbVie Inc Entertainment Health Hospitality Medicine Pharmacology Thomson Reuters Wed, 23 Jan 2013 19:30:55 +0000 Thomson Reuters 5738461 at